ATC Group: C10AX09 Ezetimibe

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C10AX09 in the ATC hierarchy

Level	Code	Title
`1`	C	Cardiovascular system
`2`	C10	Lipid modifying agents
`3`	C10A	Lipid modifying agents, plain
`4`	C10AX	Other lipid modifying agents
`5`	C10AX09	Ezetimibe

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	10 mg

Active ingredients in C10AX09

Active Ingredient
Ezetimibe
Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol.

Related product monographs

Document	Type	Information Source
EZETROL Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
EZOLETA Tablet	MPI, EU: SmPC	Medicines Authority (MT)
ZETIA Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
ZIENT Tablet	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)